Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy
Language English Country Netherlands Media print-electronic
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
27140478
DOI
10.1016/j.bbamcr.2016.04.026
PII: S0167-4889(16)30126-4
Knihovny.cz E-resources
- Keywords
- Apoptosis, Cancer, Mitochondria, Neuroblastoma, Reactive oxygen species, Respiratory chain,
- MeSH
- Antineoplastic Agents pharmacology MeSH
- Apoptosis drug effects MeSH
- Drug Resistance, Neoplasm MeSH
- Molecular Targeted Therapy * MeSH
- Cisplatin pharmacology MeSH
- Succinic Acid metabolism MeSH
- Drug Screening Assays, Antitumor MeSH
- Humans MeSH
- Mitochondria drug effects enzymology MeSH
- Cell Line, Tumor MeSH
- Neoplasm Proteins antagonists & inhibitors MeSH
- Neuroblastoma pathology MeSH
- Oxidation-Reduction MeSH
- Reactive Oxygen Species metabolism MeSH
- Electron Transport Complex II antagonists & inhibitors MeSH
- Oxygen Consumption drug effects MeSH
- Superoxides metabolism MeSH
- Drug Synergism MeSH
- Thenoyltrifluoroacetone pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Antineoplastic Agents MeSH
- Cisplatin MeSH
- Succinic Acid MeSH
- Neoplasm Proteins MeSH
- Reactive Oxygen Species MeSH
- Electron Transport Complex II MeSH
- Superoxides MeSH
- Thenoyltrifluoroacetone MeSH
Mitochondria play a pivotal role in apoptosis: permeabilization of the outer mitochondrial membrane and the release of pro-apoptotic proteins from the intermembrane space of mitochondria are regarded as the key event in apoptosis induction. Here we demonstrate how non-toxic doses of the mitochondrial Complex II inhibitor thenoyltrifluoroacetone (TTFA), which specifically inhibits the ubiquinone-binding site of succinate dehydrogenase (SDH), synergistically stimulated cell death, induced by harmless doses of cisplatin in a panel of chemoresistant neuroblastoma cell lines. Apoptotic cell death was confirmed by cytochrome c release from the mitochondria, cleavage of poly ADP-ribose polymerase, processing of caspase-3, which is an important executive enzyme in apoptosis, and caspase-3-like activity. Methyl malonate, an inhibitor of the SDHA subunit partially reversed apoptosis stimulated by TTFA in SK-N-BE(2) neuroblastoma cells (NB), indicating that sensitization requires oxidation of succinate. In contrast, in IMR-32 NB cells, the same concentrations of TTFA markedly suppressed cisplatin-induced apoptosis. Comparison of oxygen consumption in cisplatin-resistant SK-N-BE(2) and cisplatin-sensitive IMR-32 cells clearly demonstrated impaired Complex II activity in IMR-32 cells. We also found that in SK-N-BE(2) cells co-treatment with cisplatin and TTFA markedly stimulated formation of reactive oxygen species (ROS), whereas in IMR cells, cisplatin-mediated ROS production was attenuated by TTFA, which explains apoptosis suppression in these cells. Thus, functionally active SDH is a prerequisite for the ROS-mediated sensitization to treatment by TTFA.
References provided by Crossref.org
Mitochondrial complex II and reactive oxygen species in disease and therapy